Gene · 28234
Papers2,854
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,854
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Dicloxacillin and flucloxacillin inhibit hepatic uptake transporters -in vitro investigations and physiologically based pharmacokinetic modelling. | bioRxiv | 2025 | 41278897 | PubTator, text mining | PubMed |
| Association Study of OATP1B3 Polymorphisms on Hepatic Uptake and Drug-Drug Interaction In Vitro. | ACS Omega | 2025 | 41244417 | PubTator, text mining | PubMed |
| Construction and validation of an anoikis-related prognostic model for lung adenocarcinoma based on bulk and single-cell transcriptomic data. | PLoS One | 2025 | 41187171 | PubTator, text mining | PubMed |
| CTTN overexpression in HNSCC inhibits Anoikis-apoptosis. | Sci Rep | 2025 | 41168318 | PubTator, text mining | PubMed |
| Profiling Interactions Between Bicyclol and SLC/ABC Transporters: Advancing Clinical Safety and Efficacy in Combination Therapy. | Pharm Res | 2025 | 41145746 | PubTator, text mining | PubMed |
| Important role of OATP in the liver disposition of ezetimibe and its consequent glucuronidation metabolite. | Drug Metab Pharmacokinet | 2025 | 41106224 | PubTator, text mining | PubMed |
| Effects of nonsense genetic variants on OATP1B1 expression and transport activity in vitro. | Eur J Pharm Sci | 2025 | 41082948 | PubTator, text mining | PubMed |
| Elucidate biomarkers and the molecular pathways associated with genetic variants that contribute to the etiology of Parkinson's disease. | Acta Neurol Belg | 2025 | 41026459 | PubTator, text mining | PubMed |
| Molecular markers of treatment irregularity of statins: influence of polymorphisms in SLCO1B1 and SLCO1B3. | Pharmacogenomics | 2025 | 41020786 | PubTator, text mining | PubMed |
| Carrier cross-reactivities of the bile acid reabsorption inhibitors elobixibat, linerixibat, maralixibat, and odevixibat. | J Lipid Res | 2025 | 40998033 | PubTator, text mining | PubMed |
| Navigating Drug-Drug Interactions in Clinical Drug Development: A Tutorial. | Clin Transl Sci | 2025 | 40984681 | PubTator, text mining | PubMed |
| Ibrexafungerp: Mechanism of Action, Clinical, and Translational Science. | Clin Transl Sci | 2025 | 40970688 | PubTator, text mining | PubMed |
| Quantitative analysis of coproporphyrin and its precursors as endogenous biomarkers for drug-drug interactions involving OATP1B1 and OATP1B3 in monkeys. | Drug Metab Dispos | 2025 | 40929792 | PubTator, text mining | PubMed |
| Differential Expression Patterns of SLCO Solute Carriers in Human Breast Cancer Cell Lines and Tumour Samples. | J Cell Mol Med | 2025 | 40903846 | PubTator, text mining | PubMed |
| Recurrent SLCO1B1 and SLCO1B3 mutations identified in three patients with Rotor syndrome. | Front Med (Lausanne) | 2025 | 40901525 | PubTator, text mining | PubMed |
| Structure and transport mechanism of the human prostaglandin transporter SLCO2A1. | Nat Commun | 2025 | 40885756 | PubTator, text mining | PubMed |
| Rosuvastatin PBPK Modeling: Incorporating Liver Concentrations and Effects of Ethnicity, Genetic Polymorphisms, Lactone Formation, DDI and Pregnancy. | CPT Pharmacometrics Syst Pharmacol | 2025 | 40855563 | PubTator, text mining | PubMed |
| Membrane transporter genes predict chemoradiotherapy response in patients with cervical cancer. | Einstein (Sao Paulo) | 2025 | 40834150 | PubTator, text mining | PubMed |
| Population Pharmacokinetic Modeling of Glycochenodeoxycholic Acid 3-O-Sulfate (GCDCA-S) as Endogenous Biomarker of OATP1B3 and OAT3 Transporters. | Clin Pharmacol Ther | 2025 | 40785533 | PubTator, text mining | PubMed |
| Gene polymorphisms predicting response to hydroxyurea treatment in Bahraini patients with sickle cell disease. | Expert Rev Hematol | 2025 | 40781956 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/28234/papers?page=4